Loading...

SPRY ARS PHARMACEUTICALS INC Earnings Reports 8-K Filing

RS P

SPRY

ARS PHARMACEUTICALS INC

(SPRY)

2026 8-K

Financial Results Revealed

Financial Update

Credit Agreement Signed

Patent Challenge Notice

Quarterly Earnings Report

Financial Statements

Investor Meetings

Financial Results

Financial Update

Financial Results

Collaboration Agreement

Supply Agreement

Manufacturing Agreement

Financial Results Announcement

Corporate Presentation Upda...

Presentation Update

Financial Results Announcement

Financial Results Announcement

Financial Update

Financial Results Announcement

Presentation Update

Financial Results Announcement

Annual Meeting of Stockholders

Regulation FD Disclosure

Financial Results Announcement

FDA Briefing Documents for ...

Financial Results Announcement

Presentation Update

Termination Agreement with ...

Financial Update

External Links:

On March 9, 2026, ARS Pharmaceuticals, Inc. reported its financial results for the year ending December 31, 2025, along with an updated corporate presentation for investors. This filing includes important insights regarding the company's performance and strategic direction.

AI Assistant

ARS PHARMACEUTICALS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.